This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the last few years, there have been growing calls to onshore the manufacturing of certain pharmaproducts, including active pharmaceutical ingredients (API), to ensure a smooth supply and to minimise shortages in the European Union (EU).
He told The Times of India in September 2022: “The state contributes more than 40% of pharmaproduction to the country and Hyderabad as ‘vaccine capital of the world’ played a crucial role in supplying WHO-approved vaccines globally during the pandemic.” There are fewer EMA-approved sites in the region.
Orexo also sells drugs to combat opioid misuse, including Zubsolv (buprenorphine/naloxone), which accounts for the bulk of its revenues and is funding the development of the company’s digital therapeutics as well as a pipeline of specialty pharmaproducts.
healthcare professionals (HCPs) while marketing pharmaproducts, including speaker programs. new medical or scientific information or a new FDA-approved indication for the product) or the importance of the availability of such educational programming.”
Most pharma sites operating in Russia are owned by domestic companies. There are no US FDA-approvedpharma manufacturing facilities in Russia. Pharmstandard (Moscow, Russia) and Pharmasyntez (Irkutsk Oblast, Russia) own five facilities each in Russia, the most of any pharma company.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content